Northland Securities Comments on Transcat FY2029 Earnings

Transcat, Inc. (NASDAQ:TRNS) – Northland Securities boosted their FY2029 earnings estimates for shares of Transcat in a research note issued to investors on Tuesday, January 20th. Northland Securities analyst E. Jackson now forecasts that the scientific and technical instruments company will post earnings of $2.96 per share for the year, up from their prior forecast of $2.95. Northland Securities currently has a “Strong-Buy” rating on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. Northland Securities also issued estimates for Transcat’s FY2030 earnings at $3.51 EPS.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.02). Transcat had a net margin of 3.75% and a return on equity of 6.81%. The company had revenue of $82.27 million for the quarter, compared to the consensus estimate of $79.51 million.

A number of other brokerages also recently commented on TRNS. Zacks Research upgraded shares of Transcat from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 7th. Weiss Ratings reissued a “sell (d+)” rating on shares of Transcat in a research report on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Transcat presently has an average rating of “Moderate Buy” and an average target price of $105.33.

Transcat Trading Down 1.2%

Shares of NASDAQ TRNS opened at $63.14 on Thursday. Transcat has a fifty-two week low of $50.23 and a fifty-two week high of $102.72. The company has a market cap of $589.10 million, a price-to-earnings ratio of 51.75 and a beta of 0.78. The business’s 50 day moving average price is $58.27 and its 200-day moving average price is $69.84. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.06 and a current ratio of 2.43.

Institutional Trading of Transcat

Institutional investors and hedge funds have recently modified their holdings of the stock. State of Alaska Department of Revenue acquired a new position in shares of Transcat during the third quarter valued at approximately $40,000. Lazard Asset Management LLC purchased a new stake in shares of Transcat in the 2nd quarter valued at approximately $54,000. Parkside Financial Bank & Trust purchased a new stake in shares of Transcat in the 2nd quarter valued at $79,000. PNC Financial Services Group Inc. lifted its position in shares of Transcat by 1,118.2% during the second quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company’s stock worth $92,000 after purchasing an additional 984 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Transcat by 245.5% during the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock worth $97,000 after acquiring an additional 798 shares during the period. Hedge funds and other institutional investors own 98.34% of the company’s stock.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.